Advancing Cell & Gene Therapy Through Innovative Technologies & Collaboration
Cell and Gene Therapy (CGT) is a unique field with many challenges. Gene therapy involves the transfer of genetic material, usually in a carrier or vector and the uptake of the gene into the appropriate cells of the body. While cell therapy involves the transfer of cells with the relevant function into the patient.
This case study report focuses on three key themes within the CGT space:
- Targeted CGT Therapies
- Regulatory and Commercialisation Challenges
- Digital and Systemic Advancements in CGT
Reflecting on the current state of the CGT environment, the growing interest in the sector has resulted in increased funding and clinical activity. Several obstacles still exist meaning the treatment journey for patients who may be eligible for treatment with a CGT remains uncertain. Although the future trajectory of CGTs is unpredictable, the experts in this case study report showcase important breakthroughs within the space.
